MK-0954A
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MK-0954A, covering 2011-09-01 to 2014-01-06. Get the full timeline:
Most recent: Clinical Trial Update: A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351) [Phase 3]